Theresa R. Cerulli, MD: We have heard a lot of formulations and new names thrown out today. I want to narrow our focus to 2 of the newest formulations, the 2 extended-release ADHD [attention-deficit/… [+2184 chars].
Recent FDA Approvals for ADHD Treatment - MD Magazine
